New York Society
of Interventional Pain Physicians
NYSIPP APC’s goals:
- To create an unbiased platform that improves access to evidence-based therapies in NY state through advocacy and policy.
- To create a repository of documents readily available for NYSIPP members for denial management.
Robert Tiso, MD, Syracuse
Chairman
Hemant Kalia, MD, Rochester
Vice-Chairman
Edward Rubin, MD, NYC
Board Member
Sam Nia, MD,
NYC
Board Member
Eugene Wang, MD, NYC
Board Member
Position Statements:
- NYSIPP Position Statement – Vertiflex – 2022
- NYSIPP Position Statement – mild® – 2024
- NYSIPP Position Statement – PNS – 2024
- NYSIPP Position Statement – PVA – 2024
Sample Letters:
- Vertiflex:
- SI Joint Fusion:
Public Comments – Intracept
Minutes of Meetings
AETNA – LCD Coverage
Cigna – Basivertebral Nerve Ablation
- Cigna BVNA Policy Points of Discussion Minutes 09-13-2023
- Cigna Medical Coverage Policy – Minimally Invasive Spine Surgery Procedures and Trigger Point Injections
- NASS Coverage Recommendations – Basivertebral Nerve Ablation
- NYSIPP Cigna BVN Letter
- SIS Letter
Fidelis meetings
- Fidelis/Centene epidural denials 05-16-2023
- Fidelis Zoom meeting 07-17-2025
- Fidelis Zoom meeting 10-14-2025
NGS Meetings
- Medicare/NGS – LCD clarification NGS Meeting Minutes 05-22-2023
- NGS – Curonix PNS NGS Meeting Minutes 08-22-2024
- Coding, billing NGS Meeting Minutes 07-24-2025
NYSIPP Advocacy and Policy Consortium
- Minutes from 12/06/2023
- Minutes from 1/25/2024
- Minutes from 7/15/2024
- Minutes from 12/9/2024
- Minutes from 1/6/2025
- Minutes from 3/17/2025
- Minutes from 5/19/2025
- Minutes from 9/22/2025
- Minutes from 2/2/2026
Workers’ Compensation Meetings
P2P (Provider-to-Payor) Program
The goal of this program is to foster relationships with regional payors to address their specific local coverage determinant policies to cover evidence-based, FDA-approved therapies for interventional pain management.
Please provide further information about the therapy/policy you want APC to review by clicking the button below: